Transatlantic Healthtech Fund, a first-of-its-kind venture, officially unveiled by Meridan Health Ventures
Meridian Health Ventures Launches Transatlantic Fund for UK Healthtech Startups
Meridian Health Ventures, formerly known as KHP Ventures, has announced a groundbreaking transatlantic fund dedicated to investing in early-stage UK healthtech companies. The fund, with €44 million in capital, aims to facilitate the growth and expansion of these startups into the US market, making it the world's first transatlantic HealthTech fund [1][5].
The fund's impact is significant. It provides substantial capital to UK healthtech startups, enabling them to scale their innovations internationally. By bridging market access and regulatory pathways between Europe and the US, the fund helps UK companies overcome common barriers to entry in the larger and more competitive US market [1].
The fund's portfolio includes a diverse range of leading health tech companies, such as Doccla, deepc, Patchwork, Tympa Health, Apian, iFAST Diagnostics, PocDoc, Phare Health, 52 North, and MediShout [1]. These companies are making a difference, with solutions deployed in over 100 NHS Trusts across the UK [1].
One of the fund's portfolio companies, Apian, is collaborating with Zipline and Wing to deliver care to patients faster [2]. Another, Apian, has grown through partnerships with Trusts like Guy's and St Thomas' NHS Foundation Trust and has a mission with global reach [3].
The fund's backers include prominent healthcare institutions such as Guy's and St Thomas' NHS Foundation Trust, King's College Hospital, University College London Hospitals, Cedars-Sinai Medical Center, and Hartford HealthCare [4]. These institutions see the partnership as deeply aligned with their mission to provide the best care possible to patients around the world.
Cedars-Sinai Medical Center, for instance, views the partnership as an opportunity to leverage Meridian's experience and networks in both London and the US to secure follow-on US investment, form partnerships, and commercialize technologies specifically in the US healthcare ecosystem [1].
The fund's goal is to supercharge the growth of promising innovations and deliver benefits to the NHS's patients and workforce. By bridging the gap between UK NHS and US healthcare systems for start-ups, the fund aims to support innovations that may drive improvements in healthcare delivery and outcomes on both sides of the Atlantic [6].
The NHS, facing challenges such as rising demand, increased patient acuity, and pressures on workforce and finance, is committed to harnessing digital and biomedical advances [7]. The fund will enable start-ups to generate real-world data and evidence, supporting adoption within broader UK and US healthcare environments [8].
In summary, the Meridian Health Ventures transatlantic fund is uniquely positioned to accelerate the global expansion of UK healthtech innovation by linking capital and market expertise from Europe and the US, amplifying growth prospects for startups within the fund’s portfolio. The fund's team consists of entrepreneurs, investors, operators, regulators, industry leaders, academics, and clinicians, ensuring a diverse and experienced approach to investing in and supporting these innovative companies.
[1] Meridian Health Ventures. (2022). Transatlantic Fund. Retrieved from https://meridianhealthventures.com/transatlantic-fund/
[2] Apian. (n.d.). About Us. Retrieved from https://apian.health/about-us/
[3] Meridian Health Ventures. (2022). Portfolio. Retrieved from https://meridianhealthventures.com/portfolio/
[4] Meridian Health Ventures. (2022). Backers. Retrieved from https://meridianhealthventures.com/backers/
[5] HealthTech News. (2021). Meridian Health Ventures Launches £35m Transatlantic HealthTech Fund. Retrieved from https://www.healthtechnews.eu/2021/11/24/meridian-health-ventures-launches-35m-transatlantic-healthtech-fund/
[6] Meridian Health Ventures. (2022). About Us. Retrieved from https://meridianhealthventures.com/about-us/
[7] NHS England. (2020). NHS Long Term Plan. Retrieved from https://www.longtermplan.nhs.uk/
[8] Meridian Health Ventures. (2022). The Fund. Retrieved from https://meridianhealthventures.com/the-fund/
- The transatlantic fund launched by Meridian Health Ventures is not only dedicated to investing in UK healthtech startups, but also aims to propel science-backed medical-conditions innovations, with a focus on health tech solutions that impact health-and-wellness.
- With the goal of supercharging growth, the fund's investments extend into the finance sector, providing UK healthtech startups with the necessary capital to scale their innovations not only internationally, but also in the US market, a move that involves significant investing and strong partnerships.
- The fund's investments are poised to support the development of digital health technologies, with a potential to drive improvements in healthcare delivery and outcomes, by connecting European and US healthcare ecosystems, thus enabling the commercialization of innovative health tech solutions and improving patient care on both continents.
